Overall rank by patents
#12,905
Across all tracked assignees
USPTO PatentsView assignee record - 23 granted patents across 18 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS).
The verdict
Evolved holds 23 US patents across 18 technology areas, rank #12,905 of 50,000 tracked assignees.
Evolved BY Nature, Inc. has been granted 23 US utility patents between 2019 and 2025, placing Evolved BY Nature, Inc. at rank #12,905 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.9 claims per patent with primary concentration in A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS). As a US Corporation, Evolved BY Nature, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Evolved sits between Dstillery, Inc. (23 patents, rank #12,901) and Edscha Engineering Gmbh (23 patents, rank #12,909) - the closest US assignees by grant volume. The composite Innovation Score of 56.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 2 in the 2015–2019 window, a +950% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Evolved BY Nature, Inc.'s 21.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Evolved BY Nature, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Dstillery, Inc.
23 patents
DuPont Toray Specialty Materials Kabushiki Kaisha
23 patents
EL TORO.COM, LLC
23 patents
EPIX THERAPEUTICS, INC.
23 patents
EYGS LLP
23 patents
Eargo, Inc.
23 patents
Eberhard Karls Universität Tübingen
23 patents
Edscha Engineering GmbH
23 patents
EVOLVED BY NATURE, INC.
23 patents
What this shows Evolved holds 23 patents at rank #12,905, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #12,905 in granted patent volume.
Other assignees with the most granted patents in Evolved's primary technology class.
Evolved's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 8.7% |
| 2020 | 2 | 8.7% |
| 2021 | 1 | 4.3% |
| 2022 | 6 | 26.1% |
| 2023 | 2 | 8.7% |
| 2024 | 5 | 21.7% |
| 2025 | 5 | 21.7% |
Top 15 of 18 technology areas
Overall rank by patents
#12,905
Across all tracked assignees
56.5 out of 100
How to use this portfolio
Evolved's 23 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.